The Qui Tam Team

In a new study conducted by the NEJM, researches concluded that most whistleblowers blow the whistle out of a desire to do the right thing as opposed to monetary gain.

26 whistleblowers were interviewed and 17 cases of pharmaceutical whistleblowing were studied. "The whistle-blowers need more support in the process of bringing the case forward," Dr. Aaron Kesselheim of Brigham and Women's Hospital in Boston said in a telephone interview.

In addition, the study also shows that most whistleblowers suffered some sort of backlash from their employers, which is no surprise.

Read the study

For more information:

• Reuters: Money not Major Incentive for Whistleblowers – Study
• Pharma Times: Whistleblowers Driven by Ethics, Not Cash
• HealthDay: For Drug Company Whistleblowers, Hardship Often Follows
• Investor’s Business Daily: A Desire to do the Right Thing
• Wall Street Journal: ‘I Didn’t Want to be Responsible for Somebody Dying’: Whistleblower
• Fierce Pharma: NEJM: Wherefore Art Thou Whistleblowers?
• EmaxHealth: Study Shows Whistleblowers from Drug Companies Suffer Hardships
• Heathcare Business News: Study Examines Strain Faced by Whistleblowers